Heparin

How Does Heparin Work?

Heparin works by binding to antithrombin (Antithrombin III), a naturally occurring protein in the bloodstream that inhibits clotting factors. When heparin attaches to antithrombin, it causes a conformational change that activates antithrombin approximately 1,000 times more effectively than it works on its own. This activated antithrombin then rapidly blocks two key clotting factors: Factor Xa and thrombin (Factor IIa).

By inhibiting Factor Xa and thrombin, heparin interrupts the coagulation cascade — the chain reaction of proteins that leads to clot formation. Heparin also prevents the fibrin clot from stabilizing by blocking fibrin-stabilizing factor. Importantly, heparin does not dissolve existing clots; it only prevents new clots from forming or existing ones from growing.

Heparin's anticoagulant effect is rapid (within seconds to minutes for IV dosing) and short-lived (half-life of 60-90 minutes for IV), making it highly controllable in clinical settings. If serious bleeding occurs, the antidote protamine sulfate can neutralize its effect within minutes. These pharmacokinetic properties make heparin uniquely suited for acute care settings where rapid anticoagulation and quick reversal may both be needed.

How Hard Is It to Find Heparin in Stock?

Heparin has been on the FDA drug shortage list continuously since November 2017 — one of the longest-running active shortages for any medication in the U.S. In 2026, the shortage remains active with multiple manufacturers reporting backorders or product discontinuations. Mylan (Viatris) permanently discontinued all heparin injection products in 2025. Pfizer has several key formulations on backorder, and Techdow USA is backordered with no estimated release date. Fresenius Kabi and Hikma remain the most reliably available manufacturers.

For inpatients, heparin access is managed by hospital pharmacies and is generally maintained — hospitals have contracted supply agreements and priority allocation. For outpatients filling prescriptions at retail pharmacies, availability is much more variable and changes week to week as manufacturer batches are released. Patients relying on home heparin injection (bridge therapy, pregnancy, mechanical heart valve management) are most affected.

If you or a loved one is struggling to find heparin at your pharmacy, medfinder calls pharmacies near you to check which ones have your specific formulation in stock. You provide your medication details and ZIP code, and we text you the results — typically within 24 hours. Start your search 7-10 days before you need a refill to allow time to locate stock.

Who Can Prescribe Heparin?

Heparin is not a controlled substance, so any licensed prescriber with full prescribing authority can write for it — no special DEA registration or scheduling requirements apply. However, because heparin is a high-alert medication requiring careful dose titration and monitoring, it is most commonly prescribed and managed by clinicians experienced in anticoagulation therapy.

Types of providers who commonly prescribe heparin:

Hospitalists and Critical Care Physicians — primarily manage inpatient IV heparin therapy

Cardiologists — prescribe for atrial fibrillation, mechanical heart valves, and cardiac procedures

Vascular Surgeons — use perioperatively during arterial and venous procedures

Hematologists — manage complex anticoagulation including HIT, antiphospholipid syndrome, and clotting disorders

Obstetricians and Maternal-Fetal Medicine Specialists — prescribe for pregnant patients who cannot take oral anticoagulants

Primary Care Physicians and Internists — manage bridge therapy and outpatient prophylaxis prescriptions

Nurse Practitioners (NPs) and Physician Assistants (PAs) — commonly prescribe in cardiology, hematology, and vascular medicine settings

Telehealth can support ongoing heparin management for established patients, particularly for bridge therapy prescription renewal, when coordinated with local lab monitoring. Initial anticoagulation workup and new prescribing generally requires an in-person evaluation.

Is Heparin a Controlled Substance?

No. Heparin is not a controlled substance and is not scheduled by the DEA. Any licensed prescriber with prescribing authority — including physicians, nurse practitioners, physician assistants, and in some states, pharmacists — can write a prescription for heparin without special controlled substance registration or prescription limits.

Although heparin is not a controlled substance, it is classified as a high-alert medication by the Institute for Safe Medication Practices (ISMP). This designation reflects the risk of serious harm from dosing errors — particularly errors arising from the existence of multiple heparin concentrations (1,000 units/mL, 5,000 units/mL, 10,000 units/mL, and 20,000 units/mL) that can be confused. Fatal hemorrhages have occurred due to concentration mix-ups, which is why heparin carries a boxed warning about this risk.

Refill restrictions are based on clinical necessity rather than scheduling requirements. Therapeutic IV heparin requires aPTT monitoring, and ongoing prescriptions for home use are typically renewed in coordination with the prescriber's clinical judgment.

Common Side Effects of Heparin

The most important side effect of heparin is bleeding, which is the chief complication. Because heparin reduces clotting ability, any injury may result in more bleeding than usual. Common and manageable side effects include:

Bleeding (minor bruising to major hemorrhage — most important risk)

Injection site reactions (bruising, redness, irritation)

Easy bruising throughout the body

Mild thrombocytopenia (non-immune Type I HIT, affects 10-30% of patients; usually resolves without stopping heparin)

Elevated liver enzymes (AST/ALT) — usually asymptomatic and reversible

Hyperkalemia (high potassium) — more common with prolonged use in patients with kidney disease

Serious Side Effects — Seek Immediate Medical Attention

Heparin-Induced Thrombocytopenia Type II (HIT): Immune-mediated reaction causing paradoxical dangerous clotting; occurs in 0.5-5% of UFH patients, typically 5-14 days after starting heparin; requires immediate cessation of all heparin products and alternative anticoagulation

Major hemorrhage: Intracranial, retroperitoneal, or GI bleeding — call 911 immediately if suspected

Osteoporosis: Risk with long-term use (3+ months); discuss calcium/vitamin D supplementation with prescriber

Anaphylaxis/hypersensitivity: Rare; risk increased in patients with pork allergy or sulfite sensitivity

Final Thoughts on Heparin

Heparin remains one of the most critical medications in modern medicine — irreplaceable in the acute care setting for its rapid onset, easy reversibility, and broad indications. However, its ongoing shortage since 2017, reliance on porcine-sourced supply chains, and the complexity of its monitoring requirements make it a challenging medication to manage in 2026, especially for outpatients.

Patients who rely on home heparin injections — whether for bridge therapy, pregnancy, or ongoing prophylaxis — should plan ahead, start looking for refills 7-10 days early, and have a contingency plan ready. Independent pharmacies, specialty infusion pharmacies, and hospital outpatient pharmacies are often better sources during shortage periods than large chain pharmacies.

Never go without anticoagulation therapy without medical guidance — contact your prescriber immediately if you cannot fill your prescription. And let medfinder do the pharmacy searching for you — we call pharmacies near you to find which ones have your medication in stock, so you don't have to spend hours on hold.